Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The biopreservation industry is driven by several aspects that make it important in healthcare and life sciences. The growing need for biopreservation methods to store and transfer biological samples, cells, tissues, and organs is a major driver. Effective preservation technologies are needed as biomedical research and regenerative medicine improve, propelling the biopreservation industry.
Advances in technology shape the biopreservation business. Preservation, cryopreservation, and storage improvements improve biopreservation efficiency and reliability. Biological materials can be used in research and therapeutic contexts thanks to vitrification and controlled-rate freezing.
The biopreservation market grows as the biopharmaceutical sector globalizes. Standardized and dependable biopreservation methods are needed as worldwide R&D collaborates. Biological samples must be stored and transported internationally for global research, clinical trials, and cell treatments.
Key industry players and market competition affect the Biopreservation market. Research, strategic partnerships, and new products affect market dynamics. Competition drives biopreservation technology developments, giving researchers and healthcare providers a variety of biological material preservation options.
Biopreservation is affected by customized medicine and cell-based therapy. The growing emphasis on personalized therapy necessitates the storage and preservation of patient-specific cells and tissues. Advanced biopreservation approaches are needed to develop and execute individualized medicinal interventions.
In biopreservation, regulatory compliance is also important. For cell treatments and transplantation, strict requirements protect the safety, integrity, and traceability of preserved biological resources. These guidelines increase biopreservation method confidence and encourage their wider use in healthcare.
Increasing interest in stem cell research and regenerative medicine drives biopreservation options. Stem cell storage and banking are crucial as regenerative medicine grows. Long-term stem cell storage using biopreservation methods like cryopreservation allows tissue engineering and cell-based therapy research and treatment.
COVID-19 has highlighted the necessity of biopreservation in vaccine development and delivery. Safe preservation procedures are essential for storing and transporting vaccinations and viral vectors. Global immunization initiatives have relied on biopreservation technology to maintain vaccine stability and efficacy.
Healthcare infrastructure and biotechnology investments influence biopreservation. Biobanks, cell treatment facilities, and research institutions promote sophisticated biopreservation methods. The biopreservation market grows in biotechnology and life sciences-focused countries due to modern storage and preservation facilities.
Patient awareness and advocacy boost the biopreservation sector, notably for fertility preservation. Interest in fertility preservation alternatives like oocyte and sperm banking promotes need for dependable biopreservation methods. These technologies enable infertile people to save reproductive tissue for future use, demonstrating biopreservation's social influence."
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate |   11.5% (2023–2032 |
Biopreservation Market Highlights:
Biopreservation Market Overview
The Biopreservation market is expected to reach USD 6.01 Billion at a CAGR 11.5% during the forecast period 2023-2032. Biopreservation is a use of natural flora and its antibacterial products to preserve biological material. Biopreservation is playing an important role in healthcare and food industry to preserve the biological material or food product for a long time. The increasing expenditure on healthcare, growing demand for stem cell preservation and awareness about its use with regards to treatment of diseases are expected to drive the growth of the market. Moreover, increasing awareness about personalized medicines and its applications are contributing to the growth of the biopreservation market. According to the US Food and Drug Administration (FDA), The department has approved 16 personalized medicines in the year 2017, which accounts for 20% of total drug approvals.
The rising high price of biopreservation instruments and its maintenance, stability issues related to the specimen and lack of skilled personnel for handling the biopreservation process may hamper the growth of the market during the assessment period.
Biopreservation Market Segment Insights
The biopreservation market has been segmented on the basis of product, biospecimen, and application.
Biopreservation Product Insights
On the basis of product, the market has been classified as media and equipment. The media subsegment has been further divided into nutrient media, sera, and growth factors and supplements. The equipment segment has been further divided into temperature control systems, accessories, alarms & monitoring systems, incubators, centrifuges, and other equipment. The temperature control systems segment has been further classified as freezers, cryogenic storage systems, thawing equipment, and refrigerators.Â
Biopreservation Biospecimen Insights
The biospecimen segment has been divided into human tissue samples, organs, stem cells, and other biospecimens.
Biopreservation Source Insights
The market, by source, has been segmented into regenerative medicine, biobanking, and drug discovery. On basis of regenerative medicine, the market has been divided into cell therapy, gene therapy, and others. Biobanking segment includes human egg, human sperm, and veterinary IVF.
Biopreservation Regional Insights
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biopreservation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.Â
The biopreservation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Biopreservation Market Share, by Region, 2017 (%)
Source: MRFR Analysis
The Americas are likely to dominate the global biopreservation market owing to the adoption of advanced technology, increasing spending on healthcare R&D, the presence of a well-established healthcare system, and increasing in-house sample storage in hospitals and research institutes. Moreover, presence and recent merger and acquisition activities by market players in the region are contributing to the growth of the market. For instance, in 2017, Cesca Therapeutics Inc. has acquired Sacramento’s SynGen Inc. for USD 1 million with this acquisition company has managed to add cell separation and cord blood processing products in their portfolio.
The European market is expected to be the second-largest biopreservation market. The market growth in this region can be attributed to the increasing number of births and with-it continuous increase in demand for umbilical cord preservation. According to the European Commission, in the year 2016 more than 5.1 million babies were born in Europe. Moreover, a growing number of sperm and egg banks is contributing to the growth of the market in this region.
Asia-Pacific is expected to be the fastest-growing biopreservation market during the forecast period owing to the increasing population in the region, increasing awareness about stem cell preservation and continuous development in the healthcare sector due to government funding.
The market in the Middle East & Africa is expected to account for the smallest share of the global biopreservation market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the global biopreservation market are:Â
-
Thermo Fisher Scientific Inc, - VWR International, LLC.,Â
- CUSTOM BIOGENIC SYSTEMS.,Â
-
BioLifeSolutions Inc., - BioCision.,Â
- Sigma-Aldrich Co.,Â
- QIAGEN,Â
- Lifeline Scientific,Â
- Cesca Therapeutics Inc.,Â
- Core Dynamics, Ltd.,Â
- Princeton CryoTech,Â
- Biomatrica, Inc.,Â
- Panasonic Biomedical, Inc.,Â
- Chart Industries,Â
- ATLANTA BIOLOGICALS
Biopreservation Market Segmentation
Biopreservation Product Outlook
- Media
- Nutrient Media
- Sera
- Growth Factors and Supplements
- Equipment
- Temperature Control Systems
- Freezers
- Cryogenic Storage Systems
- Thawing Equipment
- Refrigerators
- Accessories
- Alarms & Monitoring Systems
- Incubators
- Centrifuges
- Other Equipment
Biopreservation Biospecimen Outlook
- Human Tissue Samples
- Organs
- Stem Cells
- Other Biospecimens
Biopreservation Application Outlook
- Regenerative Medicine
- Cell Therapy
- Gene Therapy
- Others
- Biobanking
- Human Eggs
- Human Sperm
- Veterinary IVF
- Drug Discovery
Biopreservation Regional Outlook
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Biopreservation product manufacturers
- Biopreservation product distributors and suppliers
- Healthcare providers
- Medical device manufacturers
- Research institutes and academic centers
- Contract research organizations (CROs)
- Government associations
- Market research and consulting
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
